Sakata INX Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Sakata INX has been growing earnings at an average annual rate of 13%, while the Chemicals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 8.9% per year. Sakata INX's return on equity is 7.6%, and it has net margins of 3.8%.
Belangrijke informatie
13.0%
Groei van de winst
17.4%
Groei van de winst per aandeel
Chemicals Groei van de industrie | 6.6% |
Inkomstengroei | 8.9% |
Rendement op eigen vermogen | 7.6% |
Nettomarge | 3.8% |
Volgende winstupdate | 11 Nov 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Sakata INX geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 239,244 | 8,972 | 36,941 | 4,548 |
31 Mar 24 | 233,249 | 8,181 | 34,972 | 4,548 |
31 Dec 23 | 228,311 | 7,466 | 33,536 | 4,548 |
30 Sep 23 | 224,316 | 8,102 | 32,259 | 4,266 |
30 Jun 23 | 222,149 | 5,967 | 31,373 | 4,266 |
31 Mar 23 | 220,737 | 5,178 | 30,939 | 4,266 |
31 Dec 22 | 215,531 | 4,555 | 30,075 | 4,266 |
30 Sep 22 | 207,699 | 3,233 | 29,366 | 3,823 |
30 Jun 22 | 196,344 | 3,294 | 28,094 | 3,823 |
31 Mar 22 | 187,272 | 4,492 | 26,492 | 3,823 |
31 Dec 21 | 181,487 | 4,933 | 25,745 | 3,823 |
30 Sep 21 | 175,727 | 7,104 | 25,263 | 3,478 |
30 Jun 21 | 170,711 | 7,817 | 24,459 | 3,478 |
31 Mar 21 | 163,461 | 6,454 | 23,995 | 3,478 |
31 Dec 20 | 161,507 | 5,275 | 24,010 | 3,478 |
30 Sep 20 | 162,042 | 3,580 | 24,445 | 3,474 |
30 Jun 20 | 163,542 | 3,225 | 24,924 | 3,474 |
31 Mar 20 | 167,317 | 3,674 | 25,394 | 3,474 |
31 Dec 19 | 167,237 | 4,114 | 25,241 | 3,474 |
30 Sep 19 | 167,302 | 4,491 | 24,855 | 3,311 |
30 Jun 19 | 166,285 | 4,469 | 24,628 | 3,311 |
31 Mar 19 | 164,453 | 4,274 | 24,283 | 3,311 |
31 Dec 18 | 162,056 | 4,692 | 24,023 | 3,311 |
30 Sep 18 | 160,345 | 5,748 | 24,249 | 3,218 |
30 Jun 18 | 158,968 | 6,362 | 24,235 | 3,218 |
31 Mar 18 | 157,408 | 7,054 | 24,294 | 3,218 |
31 Dec 17 | 157,302 | 8,383 | 24,280 | 3,218 |
30 Sep 17 | 154,822 | 8,026 | 24,303 | 3,108 |
30 Jun 17 | 153,165 | 8,347 | 23,820 | 3,108 |
31 Mar 17 | 152,260 | 8,481 | 23,525 | 3,108 |
31 Dec 16 | 151,198 | 7,837 | 23,364 | 3,108 |
31 Dec 15 | 174,369 | 8,014 | 24,254 | 5,445 |
30 Sep 15 | 152,389 | 5,032 | 23,496 | 2,765 |
30 Jun 15 | 148,841 | 4,358 | 22,919 | 2,765 |
31 Mar 15 | 146,569 | 4,338 | 22,489 | 2,765 |
31 Dec 14 | 145,630 | 5,269 | 21,999 | 2,529 |
30 Sep 14 | 143,942 | 6,151 | 21,660 | 2,529 |
30 Jun 14 | 142,645 | 5,987 | 21,469 | 2,529 |
31 Mar 14 | 139,911 | 5,964 | 20,916 | 2,529 |
31 Dec 13 | 133,943 | 7,241 | 20,768 | 2,085 |
Kwaliteitswinsten: 4633 has high quality earnings.
Groeiende winstmarge: 4633's current net profit margins (3.8%) are higher than last year (2.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 4633's earnings have grown by 13% per year over the past 5 years.
Versnelling van de groei: 4633's earnings growth over the past year (50.4%) exceeds its 5-year average (13% per year).
Winst versus industrie: 4633 earnings growth over the past year (50.4%) exceeded the Chemicals industry 12.3%.
Rendement op eigen vermogen
Hoge ROE: 4633's Return on Equity (7.6%) is considered low.